HUP0402161A3 - Nicotin-or isonicotin benzothiazole derivatives, process for their preparation and pharmaceutical compositions containing them - Google Patents
Nicotin-or isonicotin benzothiazole derivatives, process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- HUP0402161A3 HUP0402161A3 HU0402161A HUP0402161A HUP0402161A3 HU P0402161 A3 HUP0402161 A3 HU P0402161A3 HU 0402161 A HU0402161 A HU 0402161A HU P0402161 A HUP0402161 A HU P0402161A HU P0402161 A3 HUP0402161 A3 HU P0402161A3
- Authority
- HU
- Hungary
- Prior art keywords
- isonicotin
- nicotin
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01127312 | 2001-11-19 | ||
PCT/EP2002/012562 WO2003043636A1 (en) | 2001-11-19 | 2002-11-11 | Nicotin-or isonicotin benzothiazole derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0402161A2 HUP0402161A2 (en) | 2005-02-28 |
HUP0402161A3 true HUP0402161A3 (en) | 2010-06-28 |
Family
ID=8179263
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0402161A HUP0402161A3 (en) | 2001-11-19 | 2002-11-11 | Nicotin-or isonicotin benzothiazole derivatives, process for their preparation and pharmaceutical compositions containing them |
Country Status (38)
Country | Link |
---|---|
US (1) | US6620811B2 (en) |
EP (1) | EP1448198B1 (en) |
JP (1) | JP4226474B2 (en) |
KR (1) | KR100577110B1 (en) |
CN (1) | CN100546580C (en) |
AR (1) | AR039367A1 (en) |
AT (1) | ATE376831T1 (en) |
AU (1) | AU2002351955B2 (en) |
BR (1) | BR0214245A (en) |
CA (1) | CA2467552C (en) |
DE (1) | DE60223278T2 (en) |
DK (1) | DK1448198T3 (en) |
EA (1) | EA007502B1 (en) |
EC (1) | ECSP045109A (en) |
ES (1) | ES2294187T3 (en) |
GT (1) | GT200200232A (en) |
HR (1) | HRP20040396A2 (en) |
HU (1) | HUP0402161A3 (en) |
IL (2) | IL161623A0 (en) |
JO (1) | JO2290B1 (en) |
MA (1) | MA27083A1 (en) |
MX (1) | MXPA04004684A (en) |
MY (1) | MY126176A (en) |
NO (1) | NO20042576L (en) |
NZ (1) | NZ532802A (en) |
PA (1) | PA8558001A1 (en) |
PE (1) | PE20030713A1 (en) |
PL (1) | PL369517A1 (en) |
PT (1) | PT1448198E (en) |
RS (1) | RS39904A (en) |
RU (1) | RU2294933C2 (en) |
SI (1) | SI1448198T1 (en) |
TN (1) | TNSN04087A1 (en) |
TW (1) | TW200407134A (en) |
UA (1) | UA77462C2 (en) |
UY (1) | UY27542A1 (en) |
WO (1) | WO2003043636A1 (en) |
ZA (1) | ZA200403817B (en) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ522928A (en) * | 2000-06-21 | 2005-05-27 | F | Benzothiazole derivatives |
US8309570B2 (en) * | 2001-06-07 | 2012-11-13 | Analgesic Neuropharmaceuticals, Llc | Treatment of central neuropathic pain |
US6734179B2 (en) * | 2001-12-12 | 2004-05-11 | Hoffmann-La Roche Inc. | Benzothiazoles |
US20050119251A1 (en) * | 2001-12-21 | 2005-06-02 | Jian-Min Fu | Nicotinamide derivatives and their use as therapeutic agents |
US7390813B1 (en) | 2001-12-21 | 2008-06-24 | Xenon Pharmaceuticals Inc. | Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents |
US6872833B2 (en) * | 2003-04-14 | 2005-03-29 | Hoffmann-La Roche Inc. | Adenosine receptor ligands |
BRPI0412257A (en) | 2003-07-23 | 2006-10-03 | Synta Pharmaceuticals Corp | compounds for inflammation and immune related uses |
EP2316827B1 (en) | 2003-07-30 | 2016-01-27 | Xenon Pharmaceuticals Inc. | Piperazine derivatives and their use as therapeutic agents |
CN1871244A (en) * | 2003-09-19 | 2006-11-29 | 弗·哈夫曼-拉罗切有限公司 | Thiazolopyridine derivatives as adenosine receptor ligands |
WO2005044793A2 (en) * | 2003-10-31 | 2005-05-19 | Takeda Pharmaceutical Company Limited | Nitrogen-containing fused heterocyclic compounds |
TWI349550B (en) | 2003-12-26 | 2011-10-01 | A thiazole derivative and adenosine a2a receptor antagonist containing the same | |
BRPI0418939A (en) * | 2004-07-06 | 2008-04-08 | Xenon Pharmaceuticals Inc | nicotinamide derivatives and their use as therapeutic agents |
JP2008506735A (en) | 2004-07-22 | 2008-03-06 | エフ.ホフマン−ラ ロシュ アーゲー | Substituted benzothiazoles |
BRPI0513511A (en) * | 2004-07-22 | 2008-05-06 | Hoffmann La Roche | benzothiazole derivatives |
KR100823799B1 (en) * | 2004-07-22 | 2008-04-21 | 에프. 호프만-라 로슈 아게 | Benzothiazole derivatives |
MX2007003318A (en) | 2004-09-20 | 2007-05-18 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes. |
CA2580845A1 (en) * | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
JP5080256B2 (en) * | 2004-09-20 | 2012-11-21 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-CoA desaturase (SCD) |
EP2269610A3 (en) * | 2004-09-20 | 2011-03-09 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
AU2005286647A1 (en) * | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
MX2007003327A (en) * | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase. |
BRPI0515488A (en) * | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | heterocyclic derivatives and their use as therapeutic agents |
CN101084207A (en) * | 2004-09-20 | 2007-12-05 | 泽农医药公司 | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
BRPI0515499A (en) * | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | pyridine derivatives for inhibition of human stearoyl coa desaturase |
ATE400557T1 (en) * | 2004-11-05 | 2008-07-15 | Hoffmann La Roche | METHOD FOR PRODUCING ISONICOTINIC ACID DERIVATIVES |
AU2006223070B2 (en) * | 2005-03-14 | 2012-02-09 | High Point Pharmaceuticals, Llc | Benzazole derivatives, compositions, and methods of use as B-secretase inhibitors |
JP2009513563A (en) * | 2005-06-03 | 2009-04-02 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors |
AU2007320906A1 (en) * | 2006-11-13 | 2008-05-22 | Pfizer Products Inc. | Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
EP2424533A4 (en) | 2009-04-27 | 2012-10-17 | High Point Pharmaceuticals Llc | Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as -secretase inhibitors |
TWI548411B (en) | 2009-04-28 | 2016-09-11 | Kyowa Hakko Kirin Co Ltd | Exercise disorder treatment |
UA110097C2 (en) | 2009-09-02 | 2015-11-25 | THERAPEUTIC AGENT FOR TREATMENT OF DISORDERS | |
UA113383C2 (en) | 2009-09-02 | 2017-01-25 | THERAPEUTIC AGENT FOR TREATMENT OF ANXIETY DISORDERS | |
JP2013522364A (en) * | 2010-03-23 | 2013-06-13 | ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー | Substituted imidazo [1,2-b] pyridazine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors |
JP5248585B2 (en) * | 2010-12-15 | 2013-07-31 | ゼノン・ファーマシューティカルズ・インコーポレイテッド | Nicotinamide derivatives and their use as therapeutic agents |
DE102011005232A1 (en) | 2011-03-08 | 2012-09-13 | AristoCon GmbH & Co. KG | Adenosine and its derivatives for use in pain therapy |
SG11201502452RA (en) | 2012-10-02 | 2015-05-28 | Epitherapeutics Aps | Inhibitors of histone demethylases |
CN111205244B (en) * | 2018-11-22 | 2023-08-18 | 上海科技大学 | Thiazolo-ring compound, preparation method, intermediate and application thereof |
DE102019110904B4 (en) * | 2019-04-26 | 2022-01-20 | Helmholtz-Zentrum Dresden - Rossendorf E. V. | N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)acetamide derivatives and their use |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0113219B1 (en) | 1982-12-21 | 1987-11-19 | Johnsen & Jorgensen (Plastics) Limited | Dispensing container |
FI91859C (en) | 1987-06-17 | 1994-08-25 | Eisai Co Ltd | Analogue method for the preparation of an active benzothiazole derivative as an antiallergic agent |
NZ522928A (en) | 2000-06-21 | 2005-05-27 | F | Benzothiazole derivatives |
-
2002
- 2002-11-05 US US10/288,100 patent/US6620811B2/en not_active Expired - Lifetime
- 2002-11-11 CA CA2467552A patent/CA2467552C/en not_active Expired - Fee Related
- 2002-11-11 DK DK02787632T patent/DK1448198T3/en active
- 2002-11-11 EA EA200400598A patent/EA007502B1/en not_active IP Right Cessation
- 2002-11-11 AU AU2002351955A patent/AU2002351955B2/en not_active Ceased
- 2002-11-11 NZ NZ532802A patent/NZ532802A/en unknown
- 2002-11-11 EP EP02787632A patent/EP1448198B1/en not_active Expired - Lifetime
- 2002-11-11 HU HU0402161A patent/HUP0402161A3/en not_active Application Discontinuation
- 2002-11-11 AT AT02787632T patent/ATE376831T1/en active
- 2002-11-11 KR KR1020047007638A patent/KR100577110B1/en not_active IP Right Cessation
- 2002-11-11 DE DE60223278T patent/DE60223278T2/en not_active Expired - Lifetime
- 2002-11-11 BR BR0214245-7A patent/BR0214245A/en not_active IP Right Cessation
- 2002-11-11 WO PCT/EP2002/012562 patent/WO2003043636A1/en active IP Right Grant
- 2002-11-11 PT PT02787632T patent/PT1448198E/en unknown
- 2002-11-11 RS YU39904A patent/RS39904A/en unknown
- 2002-11-11 SI SI200230637T patent/SI1448198T1/en unknown
- 2002-11-11 IL IL16162302A patent/IL161623A0/en unknown
- 2002-11-11 CN CNB028228391A patent/CN100546580C/en not_active Expired - Fee Related
- 2002-11-11 MX MXPA04004684A patent/MXPA04004684A/en active IP Right Grant
- 2002-11-11 RU RU2004118425/04A patent/RU2294933C2/en not_active IP Right Cessation
- 2002-11-11 PL PL02369517A patent/PL369517A1/en not_active Application Discontinuation
- 2002-11-11 JP JP2003545317A patent/JP4226474B2/en not_active Expired - Fee Related
- 2002-11-11 UA UA20040604552A patent/UA77462C2/en unknown
- 2002-11-11 ES ES02787632T patent/ES2294187T3/en not_active Expired - Lifetime
- 2002-11-14 TW TW091133371A patent/TW200407134A/en unknown
- 2002-11-14 PA PA20028558001A patent/PA8558001A1/en unknown
- 2002-11-15 PE PE2002001104A patent/PE20030713A1/en not_active Application Discontinuation
- 2002-11-18 UY UY27542A patent/UY27542A1/en not_active Application Discontinuation
- 2002-11-18 GT GT200200232A patent/GT200200232A/en unknown
- 2002-11-18 JO JO2002114A patent/JO2290B1/en active
- 2002-11-18 AR ARP020104416A patent/AR039367A1/en unknown
- 2002-11-18 MY MYPI20024303A patent/MY126176A/en unknown
-
2004
- 2004-04-26 IL IL161623A patent/IL161623A/en not_active IP Right Cessation
- 2004-05-05 HR HR20040396A patent/HRP20040396A2/en not_active Application Discontinuation
- 2004-05-17 EC EC2004005109A patent/ECSP045109A/en unknown
- 2004-05-18 ZA ZA200403817A patent/ZA200403817B/en unknown
- 2004-05-18 TN TNP2004000087A patent/TNSN04087A1/en unknown
- 2004-05-18 MA MA27681A patent/MA27083A1/en unknown
- 2004-06-18 NO NO20042576A patent/NO20042576L/en not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0402161A3 (en) | Nicotin-or isonicotin benzothiazole derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0301315A3 (en) | Benzothiazole derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
HUP0400989A3 (en) | Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0401619A3 (en) | Phenethanolamine derivatives, process for their preparation and pharmaceutical composition containing them | |
HUP0402264A3 (en) | Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof | |
IL164798A0 (en) | Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them | |
HUP0402225A3 (en) | Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them | |
HUP0401748A3 (en) | 2-amino-4,5-trisubstituted thiazolyl derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0401009A3 (en) | 1-aryl-or 1-alkylsulfonylbenzole derivatives as 5-hydroxytryptamine-6 ligands, process for their preparation and pharmaceutical compositions containing them | |
HU0103063D0 (en) | New 2h-pyridazin-3-one derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0303958A2 (en) | Heterocyclyloxy-, thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands, process for their preparation and pharmaceutical compositions containing them | |
HUP0401747A3 (en) | Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds | |
HUP0402640A3 (en) | Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands, process for their preparation and pharmaceutical compositions thereof | |
HUP0400317A3 (en) | Beta-carboline derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
HUP0303105A3 (en) | Novel aminocyclohexane derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
HUP0401082A3 (en) | Substituted 4-aminocyclohexanols, process for their preparation and pharmaceutical compositions containing them | |
HUP0204001A3 (en) | Substituted aminomethyl-phenyl-cyclohexane derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0303361A3 (en) | Substituted 1-aminobutan-3-ol derivatives, process for their preparation and pharmaceutical compositions containing them | |
SI1245565T1 (en) | Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0203859A3 (en) | Aminomethyl-phenyl-cyclohexanone derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
AU2002306687A1 (en) | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
HUP0400207A3 (en) | Substituted 4-aminocyclohexanol derivatives, process for their preparation and pharmaceutical compositions containing them | |
SI1241169T1 (en) | Isoindoloindolone derivatives, process for their preparation and pharmaceutical compositions containing them | |
HUP0304065A2 (en) | Novel 5-thio-betha-d-xylopyranoside derivatives, preparation method thereof, pharmaceutical compositions containing same and use thereof | |
HUP0401038A3 (en) | Piperazinylcarbonylquinolines and -isoquinolines, process for their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC4A | Lapse of provisional application due to refusal |